{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:56:24Z","timestamp":1791233784405,"version":"4.1.0"},"reference-count":319,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01245","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T01:58:58Z","timestamp":1575943138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":140,"title":["Diet in Parkinson's Disease: Critical Role for the Microbiome"],"prefix":"10.3389","volume":"10","author":[{"given":"Aeja","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliha","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Engen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Keshavarzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.26904","article-title":"Past, present, future of Parkinson's disease: a special essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mds.27720","article-title":"Environment, lifestyle, Parkinson's disease: Implications for prevention in the next decade","volume":"34","author":"Marras","year":"2019","journal-title":"Mov Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","article-title":"The emerging role of nutrition in Parkinson's disease","volume":"6","author":"Seidl","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","article-title":"The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies","volume":"817","author":"Perez-Pardo","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-06151-1_11","article-title":"Nutrition and gastrointestinal health as modulators of Parkinson's disease","volume-title":"Pharma-Nutrition","author":"Rassmussen","year":"2014"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-130335","article-title":"Interventions that improve body and brain bioenergetics for Parkinson's disease risk reduction and therapy","volume":"4","author":"Mattson","year":"2014","journal-title":"J Parkinsons Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6405278","DOI":"10.1155\/2017\/6405278","article-title":"Role of diet and nutritional supplements in Parkinson's disease progression","volume":"2017","author":"Mischley","year":"2017","journal-title":"Oxid Med Cell Longev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1475-2891-13-61","article-title":"Fast food fever: reviewing the impacts of the Western diet on immunity","volume":"13","author":"Myles","year":"2014","journal-title":"Nutr J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.clnu.2016.06.020","article-title":"Dietary habits and neurological features of Parkinson's disease patients: implications for practice","volume":"36","author":"Barichella","year":"2017","journal-title":"Clin Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","article-title":"Parkinson's disease from the gut","volume":"1693","author":"Liddle","year":"2018","journal-title":"Brain Res."},{"key":"B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y","article-title":"Dietary factors in Parkinson's disease: the role of food groups and specific foods","volume":"14","author":"Anderson","year":"1999","journal-title":"Mov Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/mds.27489","article-title":"Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease","volume":"34","author":"Maraki","year":"2019","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1212\/WNL.0b013e31824f7fc4","article-title":"Habitual intake of dietary flavonoids and risk of Parkinson disease","volume":"78","author":"Gao","year":"2012","journal-title":"Neurology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.arr.2011.03.001","article-title":"Impact of omega-3 fatty acids in Parkinson's disease","volume":"10","author":"Bousquet","year":"2011","journal-title":"Ageing Res Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2013.09.023","article-title":"Dietary fat intake, pesticide use, Parkinson's disease","volume":"20","author":"Kamel","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2014.01.058","article-title":"Diet and the intestinal microbiome: associations, functions, implications for health and disease","volume":"146","author":"Albenberg","year":"2014","journal-title":"Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molmet.2016.02.005","article-title":"A healthy gastrointestinal microbiome is dependent on dietary diversity","volume":"5","author":"Heiman","year":"2016","journal-title":"Mol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature."},{"key":"B24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, the risk of Parkinson's disease","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Ann Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jns.2003.07.006","article-title":"Dose-dependent protective effect of coffee, tea, smoking in Parkinson's disease: a study in ethnic Chinese","volume":"216","author":"Tan","year":"2003","journal-title":"J Neurol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JPD-171175","article-title":"Differences in Parkinson's disease risk with caffeine intake and postmenopausal hormone use","volume":"7","author":"Kim","year":"2017","journal-title":"J Parkinsons Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/mds.25076","article-title":"Caffeine and risk of Parkinson's disease in a large cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1046\/j.1471-4159.1998.71062439.x","article-title":"Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors","volume":"71","author":"Maggio","year":"1998","journal-title":"J Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.intimp.2017.11.007","article-title":"Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury","volume":"54","author":"Shi","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E12053","DOI":"10.1073\/pnas.1813365115","article-title":"Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB","volume":"115","author":"Yan","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"E642","DOI":"10.3390\/nu10050642","article-title":"Polyphenols in Parkinson's disease: a systematic review of in vivo studies","volume":"10","author":"Kujawska","year":"2018","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/ijms11041365","article-title":"Impact of dietary polyphenols on carbohydrate metabolism","volume":"11","author":"Hanhineva","year":"2010","journal-title":"Int J Mol Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.25882","article-title":"Gut feelings about smoking and coffee in Parkinson's disease","volume":"29","author":"Derkinderen","year":"2014","journal-title":"Mov Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JPD-150557","article-title":"Linking smoking, coffee, urate, Parkinson's disease - A role for gut microbiota?","volume":"5","author":"Scheperjans","year":"2015","journal-title":"J Parkinsons Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/mds.25050","article-title":"Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ana.10611","article-title":"Alcohol consumption and the incidence of Parkinson's disease","volume":"54","author":"Hern\u00e1n","year":"2003","journal-title":"Ann Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1079\/NRR2005108","article-title":"A systematic review of nutritional risk factors of Parkinson's disease","volume":"18","author":"Ishihara","year":"2005","journal-title":"Nutr Res Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.parkreldis.2008.11.011","article-title":"Alpha-synuclein, alcohol use disorders, Parkinson disease: a case-control study. Parkinsonism Relat Disord","volume":"15","author":"Brighina","year":"2009"},{"key":"B43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JPD-150533","article-title":"Alcohol consumption and Parkinson's disease risk: A review of recent findings","volume":"5","author":"Bettiol","year":"2015","journal-title":"J Parkinsons Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pnpbp.2018.04.015","article-title":"Alcohol, microbiome, their effect on psychiatric disorders","volume":"85","author":"Hillemacher","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B45","doi-asserted-by":"publisher","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B46","first-page":"223","article-title":"The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota","volume":"37","author":"Engen","year":"2015","journal-title":"Alcohol Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/aje\/kwk089","article-title":"Consumption of dairy products and risk of Parkinson's disease","volume":"165","author":"Chen","year":"2007","journal-title":"Am J Epidemiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/ana.10381","article-title":"Diet and Parkinson's disease: a potential role of dairy products in men","volume":"52","author":"Chen","year":"2002","journal-title":"Ann Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1212\/01.WNL.0000154532.98495.BF","article-title":"Consumption of milk and calcium in midlife and the future risk of Parkinson disease","volume":"64","author":"Park","year":"2005","journal-title":"Neurology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10654-012-9760-0","article-title":"Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece","volume":"28","author":"Kyrozis","year":"2013","journal-title":"Eur J Epidemiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.0000000000004057","article-title":"Intake of dairy foods and risk of Parkinson disease","volume":"89","author":"Hughes","year":"2017","journal-title":"Neurology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10654-014-9921-4","article-title":"Dairy foods intake and risk of Parkinson's disease: a dose-response meta-analysis of prospective cohort studies","volume":"29","author":"Jiang","year":"2014","journal-title":"Eur J Epidemiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1212\/WNL.0000000000002254","article-title":"Midlife milk consumption and substantia nigra neuron density at death","volume":"86","author":"Abbott","year":"2016","journal-title":"Neurology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1038\/s41598-018-29173-4","article-title":"Parkinson's disease and bacteriophages as its overlooked contributors","volume":"8","author":"Tetz","year":"2018","journal-title":"Sci Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fneur.2014.00172","article-title":"Parkinson's disease: no milk today?","volume":"5","author":"Kistner","year":"2014","journal-title":"Front Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","article-title":"Parkinson's disease and pesticides: a toxicological perspective","volume":"29","author":"Hatcher","year":"2008","journal-title":"Trends Pharmacol Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"S325","DOI":"10.3233\/JAD-2010-100363","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"20","author":"Zhu","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00018-012-0962-0","article-title":"Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases","volume":"69","author":"Salminen","year":"2012","journal-title":"Cell Mol Life Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1028415X.2017.1294555","article-title":"Gut-brain and brain-gut axis in Parkinson's disease models: effects of a uridine and fish oil diet","volume":"21","author":"Perez-Pardo","year":"2017","journal-title":"Nutr Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tips.2009.12.006","article-title":"Lessons from the rotenone model of Parkinson's disease","volume":"31","author":"Greenamyre","year":"2010","journal-title":"Trends Pharmacol Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"J Parkinsons Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol Sci."},{"key":"B65","first-page":"435","article-title":"A meta-analysis of Parkinson's disease and exposure to pesticides","volume":"21","author":"Priyadarshi","year":"2000","journal-title":"Neurotoxicology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ana.20904","article-title":"Pesticide exposure and risk for Parkinson's disease","volume":"60","author":"Ascherio","year":"2006","journal-title":"Ann Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2018","journal-title":"Gut"},{"key":"B69","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3920\/BM2017.0202","article-title":"Gut bacterial composition in a mouse model of Parkinson's disease","volume":"9","author":"Perez-Pardo","year":"2018","journal-title":"Benef Microbes."},{"key":"B70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuro.2018.02.013","article-title":"Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease","volume":"65","author":"Johnson","year":"2018","journal-title":"Neurotoxicology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/toxsci\/kfx053","article-title":"Editor's highlight: organophosphatediazinon altered quorum sensing, cell motility, stress response, carbohydrate metabolism of gut microbiome","volume":"157","author":"Gao","year":"2017","journal-title":"Toxicol Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41531-017-0035-z","article-title":"Vertebrate food products as a potential source of prion-like alpha-synuclein","volume":"3","author":"Killinger","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/138920309789351921","article-title":"Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein","volume":"10","author":"Uversky","year":"2009","journal-title":"Curr Protein Pept Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","article-title":"alpha-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B77","doi-asserted-by":"publisher","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci Transl Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","article-title":"alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature."},{"key":"B79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0146-z","article-title":"Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy","volume":"8","author":"Rota","year":"2019","journal-title":"Transl Neurodegener."},{"key":"B80","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron."},{"key":"B81","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/mi.2011.68","article-title":"M cell-depletion blocks oral prion disease pathogenesis","volume":"5","author":"Donaldson","year":"2012","journal-title":"Mucosal Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrneurol.2016.164","article-title":"Parkinson disease: LAG3 facilitates cell-to-cell spread of alpha-synuclein pathology","volume":"12","author":"Wood","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS ONE."},{"key":"B85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature."},{"key":"B86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.BAD-0019-2017","article-title":"Modulation of the gastrointestinal microbiome with nondigestible fermentable carbohydrates to improve human health","volume":"5","author":"Deehan","year":"2017","journal-title":"Microbiol Spectr."},{"key":"B89","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3389\/fmicb.2018.00890","article-title":"Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population","volume":"9","author":"Garcia-Mantrana","year":"2018","journal-title":"Front Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature18850","article-title":"Microbiome-wide association studies link dynamic microbial consortia to disease","volume":"535","author":"Gilbert","year":"2016","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40168-017-0296-0","article-title":"(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, disease","volume":"5","author":"Buford","year":"2017","journal-title":"Microbiome."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"key":"B93","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrg3182","article-title":"The human microbiome: at the interface of health and disease","volume":"13","author":"Cho","year":"2012","journal-title":"Nat Rev Genet."},{"key":"B94","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/nan.12520","article-title":"Invited review: from nose to gut - the role of the microbiome in neurological disease","volume":"45","author":"Bell","year":"2019","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-019-09320-1","article-title":"Parkinson's disease and the gastrointestinal microbiome","volume":"91","author":"Lubomski","year":"2019","journal-title":"J Neurol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.03.014","article-title":"The impact of indigenous microbes on Parkinson's disease","author":"Sampson","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2014","journal-title":"Mov Disord."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov Disord."},{"key":"B99","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature."},{"key":"B100","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/gb-2011-12-5-r50","article-title":"Moving pictures of the human microbiome","volume":"12","author":"Caporaso","year":"2011","journal-title":"Genome Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnbeh.2017.00009","article-title":"Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, cognitive impairment","volume":"11","author":"Noble","year":"2017","journal-title":"Front Behav Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e0148952","DOI":"10.1371\/journal.pone.0148952","article-title":"Lower neighborhood socioeconomic status associated with reduced diversity of the colonic microbiota in healthy adults","volume":"11","author":"Miller","year":"2016","journal-title":"PLoS ONE"},{"key":"B103","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson's disease: temporal stability and relations to disease progression","volume":"44","author":"Aho","year":"2019","journal-title":"EBioMedicine."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS ONE."},{"key":"B105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov Disord"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e0218252","DOI":"10.1371\/journal.pone.0218252","article-title":"The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function","volume":"14","author":"Mihaila","year":"2019","journal-title":"PLoS ONE"},{"key":"B107","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2017.02.026","article-title":"Oral and nasal microbiota in Parkinson's disease","volume":"38","author":"Pereira","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B108","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B109","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0451-z","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov Disord."},{"key":"B111","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson's disease and atypical Parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov Disord."},{"key":"B112","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","article-title":"Gut microbiota differs between Parkinson's disease patients and healthy controls in northeast China","volume":"12","author":"Li","year":"2019","journal-title":"Front Mol Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with Parkinson's disease","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull Exp Biol Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","article-title":"Gut microbiota in patients with Parkinson's disease in southern China","volume":"53","author":"Lin","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0142164","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS ONE"},{"key":"B116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features","volume":"60","author":"Li","year":"2017","journal-title":"Sci China Life Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","article-title":"Alteration of the fecal microbiota in Chinese patients with Parkinson's disease","volume":"70","author":"Qian","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B120","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm."},{"key":"B121","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Parkinsonism Relat Disord."},{"key":"B123","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2017.06.007","article-title":"Dietary habits in Parkinson's disease: adherence to Mediterranean diet","volume":"42","author":"Cassani","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B125","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","article-title":"Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites","volume":"16","author":"Zhou","year":"2019","journal-title":"Neurotherapeutics."},{"key":"B126","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson's disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology."},{"key":"B127","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in Parkinson's disease: subjective symptoms, objective markers, new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov Disord."},{"key":"B128","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.dld.2005.06.008","article-title":"Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation","volume":"37","author":"Khalif","year":"2005","journal-title":"Dig Liver Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.expneurol.2012.08.018","article-title":"Circadian and sleep disorders in Parkinson's disease","volume":"243","author":"Videnovic","year":"2013","journal-title":"Exp Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/mds.26509","article-title":"Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?","volume":"31","author":"Videnovic","year":"2016","journal-title":"Mov Disord."},{"key":"B131","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/bs.irn.2016.07.002","article-title":"Circadian rhythm and the gut microbiome","volume":"131","author":"Voigt","year":"2016","journal-title":"Int Rev Neurobiol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.tig.2017.07.010","article-title":"Circadian clocks and metabolism: implications for microbiome and aging","volume":"33","author":"Paschos","year":"2017","journal-title":"Trends Genet."},{"key":"B133","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.3233\/JPD-181477","article-title":"The gut and Parkinson's disease: hype or hope?","volume":"8","author":"Scheperjans","year":"2018","journal-title":"J Parkinsons Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B135","doi-asserted-by":"publisher","first-page":"9869712","DOI":"10.1155\/2016\/9869712","article-title":"An integrated review of psychological stress in Parkinson's disease: biological mechanisms and symptom and health outcomes","volume":"2016","author":"Austin","year":"2016","journal-title":"Parkinsons Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.3233\/JPD-181493","article-title":"The search for environmental causes of Parkinson's disease: moving forward","volume":"8","author":"Chen","year":"2018","journal-title":"J Parkinsons Dis."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.12.012","article-title":"Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease","author":"Dodiya","year":"2018","journal-title":"Neurobiol Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1249\/MSS.0000000000001495","article-title":"Exercise alters gut microbiota composition and function in lean and obese humans","volume":"50","author":"Allen","year":"2018","journal-title":"Med Sci Sports Exerc."},{"key":"B139","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/mds.27138","article-title":"How does Parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, histology","volume":"33","author":"Borghammer","year":"2018","journal-title":"Mov Disord."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","article-title":"Does Parkinson's disease start in the gut?","volume":"135","author":"Lionnet","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B142","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/mds.22369","article-title":"Transplanted dopaminergic neurons develop PD pathologic changes: a second case report","volume":"23","author":"Kordower","year":"2008","journal-title":"Mov Disord."},{"key":"B144","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"E3573","DOI":"10.3390\/ijms19113573","article-title":"What is the evidence that Parkinson's disease is a prion disorder, which originates in the gut?","volume":"19","author":"Kujawska","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","article-title":"\u03b1-synuclein in Parkinson's disease: causal or bystander?","volume":"126","author":"Riederer","year":"2019","journal-title":"J Neural Transm"},{"key":"B147","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fneur.2019.00574","article-title":"The gut and Parkinson's disease-a bidirectional pathway","volume":"10","author":"Santos","year":"2019","journal-title":"Front Neurol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40473-017-0129-2","article-title":"Microbes tickling your tummy: the importance of the gut-brain axis in Parkinson's Disease","volume":"4","author":"Perez-Pardo","year":"2017","journal-title":"Curr Behav Neurosci Rep."},{"key":"B149","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","article-title":"The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery","volume":"22","author":"Dutta","year":"2008","journal-title":"Fundam Clin Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fcimb.2017.00318","article-title":"Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus","volume":"7","author":"Zhao","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","article-title":"Control of brain development, function, behavior by the microbiome","volume":"17","author":"Sampson","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B152","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2016.02.009","article-title":"Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?","volume":"625","author":"Bourassa","year":"2016","journal-title":"Neurosci Lett."},{"key":"B153","first-page":"cer-04-17","article-title":"Gut feelings on Parkinson's and depression","volume":"2017","author":"Dinan","year":"2017","journal-title":"Cerebrum."},{"key":"B154","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11154-014-9288-6","article-title":"Gut microbiota and GLP-1","volume":"15","author":"Everard","year":"2014","journal-title":"Rev Endocr Metab Disord."},{"key":"B155","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","article-title":"Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1","volume":"381","author":"Liu","year":"2017","journal-title":"J Neurol Sci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord."},{"key":"B157","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord."},{"key":"B158","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson' disease","volume":"30","author":"Lebouvier","year":"2009","journal-title":"Eur J Neurosci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mds.26480","article-title":"Gut feelings about alpha-synuclein in gastrointestinal biopsies: biomarker in the making?","volume":"31","author":"Ruffmann","year":"2016","journal-title":"Mov Disord."},{"key":"B160","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann Neurol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JPD-161050","article-title":"Objective colonic dysfunction is far more prevalent than subjective constipation in Parkinson's disease: a colon transit and volume study","volume":"7","author":"Knudsen","year":"2017","journal-title":"J Parkinsons Dis."},{"key":"B162","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: sporadic Parkinson's disease: development and distribution of alpha-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science."},{"key":"B164","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ana.24531","article-title":"Does vagotomy reduce the risk of Parkinson's disease?","volume":"78","author":"Tysnes","year":"2015","journal-title":"Ann Neurol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology."},{"key":"B167","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","article-title":"Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration","volume":"595","author":"Dinan","year":"2017","journal-title":"J Physiol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20180794","article-title":"Microbiome-microglia connections via the gut-brain axis","volume":"216","author":"Abdel-Haq","year":"2018","journal-title":"J Exp Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","article-title":"Gut microbes and the brain: paradigm shift in neuroscience","volume":"34","author":"Mayer","year":"2014","journal-title":"J Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-alpha signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B171","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson's disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell."},{"key":"B174","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"Athauda","year":"2016","journal-title":"Drug Discov Tdy."},{"key":"B175","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/microorganisms6040107","article-title":"Leaky gut, leaky brain?","volume":"6","author":"Obrenovich","year":"2018","journal-title":"Microorganisms."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"B177","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.coph.2013.08.006","article-title":"Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host","volume":"13","author":"Ganapathy","year":"2013","journal-title":"Curr Opin Pharmacol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"56071","DOI":"10.18632\/oncotarget.11267","article-title":"Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.cell.2017.05.048","article-title":"Microbiome and longevity: gut microbes send signals to host mitochondria","volume":"169","author":"Gruber","year":"2017","journal-title":"Cell."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.celrep.2016.05.047","article-title":"Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways","volume":"15","author":"Tan","year":"2016","journal-title":"Cell Rep."},{"key":"B181","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","article-title":"Structural alterations of the intestinal epithelial barrier in Parkinson's disease","volume":"3","author":"Clairembault","year":"2015","journal-title":"Acta Neuropathol Commun."},{"key":"B182","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B183","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ibd\/izy190","article-title":"Inflammatory bowel disease and Parkinson's disease: a nationwide Swedish Cohort Study","volume":"25","author":"Weimers","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"B184","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014","volume":"68","author":"Villumsen","year":"2018","journal-title":"Gut."},{"key":"B185","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/MIB.0000000000000735","article-title":"Association between Parkinson's disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort study","volume":"22","author":"Lin","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","article-title":"The risk of Parkinson's disease in inflammatory bowel disease: a systematic review and meta-analysis","volume":"51","author":"Zhu","year":"2019","journal-title":"Dig Liver Dis."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1471-4159.2010.06879.x","article-title":"Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease","volume":"114","author":"Villar\u00e1n","year":"2010","journal-title":"J Neurochem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","article-title":"Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in alpha-synuclein mutant mice","volume":"21","author":"Kishimoto","year":"2019","journal-title":"Neuromolecular Med."},{"key":"B190","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2018.02.008","article-title":"Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries","volume":"50","author":"Camacho-Soto","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B191","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-319-49969-7_9","article-title":"Models of LRRK2-associated Parkinson's disease","volume":"14","author":"Xiong","year":"2017","journal-title":"Adv Neurobiol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota axis in Alzheimer's disease","volume":"25","author":"Kowalski","year":"2019","journal-title":"J Neurogastroenterol Motil."},{"key":"B193","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","article-title":"Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)","volume":"206","author":"Zhang","year":"2009","journal-title":"J Neuroimmunol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3389\/fimmu.2017.01064","article-title":"Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer's disease brain","volume":"8","author":"Zhao","year":"2017","journal-title":"Front Immunol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"21528","DOI":"10.1073\/pnas.1215849110","article-title":"Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila","volume":"109","author":"Rera","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B196","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fgene.2016.00212","article-title":"Classifying aging as a disease: the role of microbes","volume":"7","author":"Lustgarten","year":"2016","journal-title":"Front Genet."},{"key":"B197","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"B198","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fimmu.2014.00060","article-title":"Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics","volume":"5","author":"de Kivit","year":"2014","journal-title":"Front Immunol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp Mol Med."},{"key":"B200","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.neuro.2008.02.014","article-title":"Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits","volume":"29","author":"Liu","year":"2008","journal-title":"Neurotoxicology."},{"key":"B201","doi-asserted-by":"publisher","first-page":"E1689","DOI":"10.3390\/ijms19061689","article-title":"Microbiome-gut-brain axis and toll-like receptors in Parkinson's disease","volume":"19","author":"Caputi","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","article-title":"Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease","volume":"3","author":"Noelker","year":"2013","journal-title":"Sci Rep."},{"key":"B203","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.2174\/1381612822666160907093807","article-title":"The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in Alzheimer's disease","volume":"22","author":"K\u00f6hler","year":"2016","journal-title":"Curr Pharm Des."},{"key":"B204","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11357-018-0026-y","article-title":"Composition and richness of the serum microbiome differ by age and link to systemic inflammation","volume":"40","author":"Buford","year":"2018","journal-title":"Geroscience."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"B206","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med."},{"key":"B208","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.13217","article-title":"The pathogenic role of the inflammasome in neurodegenerative diseases","volume":"136","author":"Freeman","year":"2015","journal-title":"J Neurochem."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat Rev Neurosci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science."},{"key":"B212","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS ONE."},{"key":"B213","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol Rev."},{"key":"B214","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2018","journal-title":"Cell Death Differ."},{"key":"B215","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","article-title":"Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease","volume":"3","author":"Sarkar","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"B216","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/WNR.0000000000000871","article-title":"Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson's disease: involvement of the PI3K\/Akt\/mTOR pathway","volume":"28","author":"Giacoppo","year":"2017","journal-title":"Neuroreport."},{"key":"B217","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-018-1282-6","article-title":"Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia\/reperfusion injury","volume":"15","author":"Gong","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B218","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metab."},{"key":"B219","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/bpa.12483","article-title":"Inflammasome activation and innate immunity in Alzheimer's disease","volume":"27","author":"Heneka","year":"2017","journal-title":"Brain Pathol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kfy219","article-title":"Inflammasomes: an emerging mechanism translating environmental toxicant exposure into neuroinflammation in Parkinson's disease","volume":"166","author":"Anderson","year":"2018","journal-title":"Toxicol Sci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/jnr.22343","article-title":"Inflammasome signaling at the heart of central nervous system pathology","volume":"88","author":"Chakraborty","year":"2010","journal-title":"J Neurosci Res."},{"key":"B222","doi-asserted-by":"publisher","first-page":"99740","DOI":"10.18632\/oncotarget.20763","article-title":"NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction","volume":"8","author":"Pavillard","year":"2017","journal-title":"Oncotarget."},{"key":"B223","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1096\/fj.201700984RR","article-title":"Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, reduced neuroplasticity","volume":"32","author":"Jena","year":"2018","journal-title":"FASEB J."},{"key":"B224","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.10.009","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"B225","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med."},{"key":"B226","doi-asserted-by":"publisher","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B227","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2017.09.016","article-title":"Reduced brain insulin signaling: a seminal process in Alzheimer's disease pathogenesis","volume":"136","author":"Bloom","year":"2017","journal-title":"Neuropharmacology."},{"key":"B228","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin resistance and Parkinson's disease: a new target for disease modification?","author":"Athauda","year":"2016","journal-title":"Prog Neurobiol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson's disease, insulin resistance and novel agents of neuroprotection","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain."},{"key":"B230","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrmicro.2016.83","article-title":"Metagenome-wide association studies: fine-mining the microbiome","volume":"14","author":"Wang","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","article-title":"Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study","volume":"91","author":"De","year":"2018","journal-title":"Neurology."},{"key":"B232","doi-asserted-by":"publisher","first-page":"e83940","DOI":"10.1371\/journal.pone.0083940","article-title":"Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes","volume":"8","author":"Alters","year":"2013","journal-title":"PLoS ONE."},{"key":"B233","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","article-title":"Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort","volume":"18","author":"Wahlqvist","year":"2012","journal-title":"Parkinsonism Relat Disord."},{"key":"B234","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","article-title":"Type 2 diabetes and the risk of Parkinson's disease","volume":"30","author":"Hu","year":"2007","journal-title":"Diabetes Care."},{"key":"B235","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"B236","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature."},{"key":"B237","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med."},{"key":"B238","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbr.2018.06.005","article-title":"PPARss\/delta agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease","volume":"356","author":"Chen","year":"2018","journal-title":"Behav Brain Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"E562","DOI":"10.3390\/ijms18030562","article-title":"Inhibition of NLRP3 inflammasome pathway by butyrate improves corneal wound healing in corneal alkali burn","volume":"18","author":"Bian","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B240","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/jpet.116.232934","article-title":"Inhibition of the inflammasome NLRP3 by arglabin attenuates inflammation, protects pancreatic beta-cells from apoptosis, prevents type 2 diabetes mellitus development in ApoE2Ki mice on a chronic high-fat diet","volume":"357","author":"Abderrazak","year":"2016","journal-title":"J Pharmacol Exp Ther."},{"key":"B241","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr Metab"},{"key":"B242","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2011","journal-title":"Diabetes."},{"key":"B243","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1113\/jphysiol.2008.164012","article-title":"Nutritional regulation of glucagon-like peptide-1 secretion","volume":"587","author":"Tolhurst","year":"2009","journal-title":"J Physiol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2018.03.142","article-title":"Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1\/NOX4\/ROS pathway in H9c2 cells","volume":"499","author":"Chen","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B245","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10557-014-6539-4","article-title":"DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway","volume":"28","author":"Dai","year":"2014","journal-title":"Cardiovasc Drugs Ther."},{"key":"B246","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease","volume":"202","author":"Kim","year":"2009","journal-title":"J Endocrinol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"Holscher","year":"2014","journal-title":"J Endocrinol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/0963689717721234","article-title":"A new treatment strategy for Parkinson's disease through the gut-brain axis: the glucagon-like peptide-1 receptor pathway","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Transplant."},{"key":"B249","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jdi.12464","article-title":"Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist","volume":"7","author":"Katsurada","year":"2016","journal-title":"J Diabetes Investig."},{"key":"B250","first-page":"1021","article-title":"BDNF in the aged brain: translational implications for Parkinson's disease","volume":"2","author":"Mercado","year":"2017","journal-title":"Austin Neurol Neurosci."},{"key":"B251","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.05.023","article-title":"Low BDNF is associated with cognitive impairments in patients with Parkinson's disease","volume":"29","author":"Wang","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B252","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/jdi.12762","article-title":"Regulation of glucagon-like peptide-1 sensitivity by gut microbiota dysbiosis","volume":"9","author":"Yamane","year":"2017","journal-title":"J Diabetes Investig."},{"key":"B253","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1742-2094-9-276","article-title":"GLP-1 secretion by microglial cells and decreased CNS expression in obesity","volume":"9","author":"Kappe","year":"2012","journal-title":"J Neuroinflammation."},{"key":"B254","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","article-title":"The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice","volume":"141","author":"Bercik","year":"2011","journal-title":"Gastroenterology."},{"key":"B255","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.neuropharm.2018.02.012","article-title":"Two novel dual GLP-1\/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease","volume":"133","author":"Feng","year":"2018","journal-title":"Neuropharmacology."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2015.09.035","article-title":"A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BND","volume":"1634","author":"Ji","year":"2015","journal-title":"Brain Res"},{"key":"B257","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","article-title":"Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease","volume":"136","author":"Athauda","year":"2018","journal-title":"Neuropharmacology."},{"key":"B258","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet."},{"key":"B259","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/mnfr.201500406","article-title":"Talking microbes: When gut bacteria interact with diet and host organs","volume":"60","author":"Cani","year":"2016","journal-title":"Mol Nutr Food Res."},{"key":"B260","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.euroneuro.2017.12.004","article-title":"The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus","volume":"28","author":"O'Leary","year":"2018","journal-title":"Eur Neuropsychopharmacol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1212\/WNL.0000000000002387","article-title":"Higher brain BDNF gene expression is associated with slower cognitive decline in older adults","volume":"86","author":"Buchman","year":"2016","journal-title":"Neurology"},{"key":"B262","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11011-017-9997-0","article-title":"The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): kill two birds with one stone","volume":"32","author":"Motamedi","year":"2014","journal-title":"Metab Brain Dis."},{"key":"B263","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12035-014-8914-3","article-title":"Sodium butyrate prevents memory impairment by re-establishing BDNF and GDNF expression in experimental pneumococcal meningitis","volume":"52","author":"Barichello","year":"2015","journal-title":"Mol Neurobiol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","article-title":"Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra","volume":"166","author":"Howells","year":"2000","journal-title":"Exp Neurol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2018.10.006","article-title":"Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: a systematic review and meta-analysis","volume":"1704","author":"Rahmani","year":"2018","journal-title":"Brain Res."},{"key":"B266","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s11064-016-2039-1","article-title":"The gut-brain axis, BDNF, NMDA and CNS disorders","volume":"41","author":"Maqsood","year":"2016","journal-title":"Neurochem Res."},{"key":"B267","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.physbeh.2017.02.027","article-title":"Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity","volume":"173","author":"Sen","year":"2017","journal-title":"Physiol Behav."},{"key":"B268","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00415-017-8639-0","article-title":"Nutritional habits, risk, progression of Parkinson disease","volume":"265","author":"Erro","year":"2017","journal-title":"J Neurol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/ajcn\/86.5.1486","article-title":"Prospective study of dietary pattern and risk of Parkinson disease","volume":"86","author":"Gao","year":"2007","journal-title":"Am J Clin Nutr."},{"key":"B270","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.24918","article-title":"The association between Mediterranean diet adherence and Parkinson's disease","volume":"27","author":"Alcalay","year":"2012","journal-title":"Mov Disord."},{"key":"B271","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1186\/gb-2014-15-7-r89","article-title":"Host lifestyle affects human microbiota on daily timescales","volume":"15","author":"David","year":"2014","journal-title":"Genome Biol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1038\/s41598-017-02546-x","article-title":"Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight\/obese men: a randomized crossover trial","volume":"7","author":"Canfora","year":"2017","journal-title":"Sci Rep."},{"key":"B274","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab."},{"key":"B275","doi-asserted-by":"publisher","first-page":"5460302","DOI":"10.1155\/2016\/5460302","article-title":"Natural compounds as regulators of NLRP3 inflammasome-mediated IL-1\u03b2 production","volume":"2016","author":"Tozser","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B276","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","article-title":"Impact of intermittent fasting on health and disease processes","volume":"39","author":"Mattson","year":"2016","journal-title":"Ageing Res Rev."},{"key":"B277","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of brain aging: adaptive and pathological modification by metabolic states","volume":"27","author":"Mattson","year":"2018","journal-title":"Cell Metab."},{"key":"B278","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrn.2017.156","article-title":"Intermittent metabolic switching, neuroplasticity and brain health","volume":"19","author":"Mattson","year":"2018","journal-title":"Nat Rev Neurosci."},{"key":"B279","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnut.2019.00063","article-title":"The mechanisms by which the ketone body D-\u03b2-hydroxybutyrate may improve the multiple cellular pathologies of Parkinson's disease","volume":"6","author":"Norwitz","year":"2019","journal-title":"Front Nutr."},{"key":"B280","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab."},{"key":"B281","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P","article-title":"Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease","volume":"57","author":"Duan","year":"1999","journal-title":"J Neurosci Res."},{"key":"B282","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0405831102","article-title":"Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease","volume":"101","author":"Maswood","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B283","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.brainresrev.2008.09.002","article-title":"The neuroprotective properties of calorie restriction, the ketogenic diet, ketone bodies","volume":"59","author":"Maalouf","year":"2009","journal-title":"Brain Res Rev."},{"key":"B284","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"64","author":"Vanitallie","year":"2005","journal-title":"Neurology"},{"key":"B285","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2202-11-51","article-title":"Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury","volume":"11","author":"Cornille","year":"2010","journal-title":"BMC Neurosci."},{"key":"B286","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-\u03b2-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J Clin Invest."},{"key":"B287","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med."},{"key":"B288","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.1074\/jbc.M117.791715","article-title":"Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2","volume":"292","author":"Traba","year":"2017","journal-title":"J Biol Chem."},{"key":"B289","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1172\/JCI83260","article-title":"Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects","volume":"125","author":"Traba","year":"2015","journal-title":"J Clin Invest."},{"key":"B290","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"\u03b2-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep."},{"key":"B291","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.cmet.2017.08.019","article-title":"Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota","volume":"26","author":"Li","year":"2017","journal-title":"Cell Metab."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2337\/db18-0158","article-title":"Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db\/db mice","volume":"67","author":"Beli","year":"2018","journal-title":"Diabetes."},{"key":"B293","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","article-title":"Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation","volume":"15","author":"Moon","year":"2009","journal-title":"Neurotox Res."},{"key":"B294","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2042018813479645","article-title":"Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection","volume":"4","author":"Bayliss","year":"2013","journal-title":"Ther Adv Endocrinol Metab."},{"key":"B295","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","article-title":"Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism","volume":"29","author":"Andrews","year":"2009","journal-title":"J Neurosci."},{"key":"B296","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"Dyall","year":"2015","journal-title":"Front Aging Neurosci."},{"key":"B297","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"da Silva","year":"2008","journal-title":"J Affect Disord."},{"key":"B298","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbr.2011.09.033","article-title":"Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease","volume":"226","author":"Luchtman","year":"2012","journal-title":"Behav Brain Res."},{"key":"B299","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1471-4159.2009.06524.x","article-title":"Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1\u03b2 administrations: effects of omega-3 fatty acid EPA treatment","volume":"112","author":"Taepavarapruk","year":"2010","journal-title":"J Neurochem."},{"key":"B300","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2010.09.046","article-title":"Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices","volume":"649","author":"Meng","year":"2010","journal-title":"Eur J Pharmacol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/jnc.12068","article-title":"omega-3 fatty acid eicosapentaenoic acid attenuates MPP+-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells","volume":"124","author":"Luchtman","year":"2013","journal-title":"J Neurochem."},{"key":"B302","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neures.2008.07.005","article-title":"Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease","volume":"62","author":"Cansev","year":"2008","journal-title":"Neurosci Res."},{"key":"B303","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnagi.2017.00057","article-title":"Promising effects of neurorestorative diets on motor, cognitive, gastrointestinal dysfunction after symptom development in a mouse model of Parkinson's disease","volume":"9","author":"Perez-Pardo","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B304","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.neuint.2011.06.012","article-title":"The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease","volume":"59","author":"Ozsoy","year":"2011","journal-title":"Neurochem Int."},{"key":"B305","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","article-title":"Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease","volume":"22","author":"Calon","year":"2005","journal-title":"Eur J Neurosci."},{"key":"B306","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","article-title":"Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels","volume":"27","author":"Green","year":"2007","journal-title":"J Neurosci."},{"key":"B307","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2007.08.089","article-title":"Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus","volume":"1182","author":"Sakamoto","year":"2007","journal-title":"Brain Res."},{"key":"B308","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem Rev."},{"key":"B309","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","article-title":"Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection","volume":"81","author":"Bazan","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"B310","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.3892\/mmr.2016.4980","article-title":"Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-kappaB-mediated CX3CL1\/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation","volume":"13","author":"Ren","year":"2016","journal-title":"Mol Med Rep."},{"key":"B311","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.expneurol.2017.01.005","article-title":"Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury","volume":"290","author":"Lin","year":"2017","journal-title":"Exp Neurol."},{"key":"B312","doi-asserted-by":"publisher","first-page":"1759091415618969","DOI":"10.1177\/1759091415618969","article-title":"Administration of DHA reduces endoplasmic reticulum stress-associated inflammation and alters microglial or macrophage activation in traumatic brain injury","volume":"7","author":"Harvey","year":"2015","journal-title":"ASN Neuro."},{"key":"B313","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.3748\/wjg.v22.i8.2533","article-title":"Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation","volume":"22","author":"Sui","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity."},{"key":"B315","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","article-title":"Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model","volume":"43","author":"Calon","year":"2004","journal-title":"Neuron"},{"key":"B316","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1089\/neu.2004.21.1457","article-title":"Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, counteract learning disability after traumatic brain injury in rats","volume":"21","author":"Wu","year":"2004","journal-title":"J Neurotrauma."},{"key":"B317","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/jn\/135.3.549","article-title":"Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats","volume":"135","author":"Hashimoto","year":"2005","journal-title":"J Nutr."},{"key":"B318","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1046\/j.1471-4159.2000.0752563.x","article-title":"Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration","volume":"75","author":"Moriguchi","year":"2000","journal-title":"J Neurochem."},{"key":"B319","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1126\/science.290.5499.2140","article-title":"Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain","volume":"290","author":"de Urquiza","year":"2000","journal-title":"Science"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T01:59:06Z","timestamp":1575943146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":319,"alternative-id":["10.3389\/fneur.2019.01245"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01245","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"article-number":"1245"}}